Streptococcus pyogenes Pharyngeal Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Mechanisms of Resistance and Clonal Diversity
Open Access
- 1 January 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (1) , 418-420
Abstract
A survey of emm gene sequences and an analysis of the pulsed-field electrophoretic profiles of 30 Streptococcus pyogenes isolates with reduced susceptibilities to ciprofloxacin detected the prevalence of isolates with emm type 6 and considerable genetic diversity among isolates. The mechanism of ciprofloxacin resistance in these isolates was based on point mutations in topoisomerase IV subunit C encoded by parC , mainly replacement of serine-79 by alanine.Keywords
This publication has 15 references indexed in Scilit:
- High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in GermanyClinical Microbiology and Infection, 2004
- Survey of emm Gene Sequences from Pharyngeal Streptococcus pyogenes Isolates Collected in Spain and Their Relationship with Erythromycin SusceptibilityJournal of Clinical Microbiology, 2003
- Fluoroquinolone Resistance inStreptococcus pyogenesClinical Infectious Diseases, 2003
- Erythromycin-Resistant Group A Streptococci in Schoolchildren in PittsburghNew England Journal of Medicine, 2002
- Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998–1999) Multicenter Surveillance Study in SpainAntimicrobial Agents and Chemotherapy, 2001
- Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)Journal of Antimicrobial Chemotherapy, 2000
- Resistance to Multiple Fluoroquinolones in a Clinical Isolate of Streptococcus pyogenes : Identification of gyrA and parC and Specification of Point Mutations Associated with ResistanceAntimicrobial Agents and Chemotherapy, 2000
- A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new ‘respiratory quinolones’Journal of Antimicrobial Chemotherapy, 1999
- Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A StreptococcusMolecular Microbiology, 1998
- Resistance to Erythromycin in Group A StreptococciNew England Journal of Medicine, 1992